title: Effects of 12 beticolins, Cercospora beticola toxins, on proliferation of ras-transformed adrenocortical cell.
abstract: OBJECTIVE
  To explore different effects of 12 beticolins, Cercospora beticola toxins, on ras-transformed adrenocortical cell growth inhibition and their functional mechanism.
  
  
  METHODS
  Beticolin-induced inhibition was measured with survival cell number determined by an automated photocolorimetric method. The penetration of beticolin was examined by confocal microscopy. Ras protein determined by Lowry method were separated by 14 % SDS-PAGE and electroblotted to Immobilon-P transfer membrane and detected with pan-Ras (Ab-3) monoclonal antibody. The Ca2+ chelation by beticolin was investigated using a calcium ionophore.
  
  
  RESULTS
  Cell growth inhibition was found dose- and time-dependently at submicromolar level for beticolin-1, -2, and -13 (IC50 </= 250 nmol/L) and for beticolin-0, 6, and -11 (400 nmol/L < IC50 </= 500 nmol/L). The inhibition by beticolin-1 was immediate, independent of cell culture step and not reversible for 3-day treatment. Beticolin-3 and -4 were slightly active (1 micromol/L < IC50 </= 2 micromol/L) and beticolin-7, -9, -12, and -5 were inactive at micromolar level. The beticolin-induced cell growth inhibition was correlated with the hydrophobicity of these compounds. Beticolin-1 fluorescence in RTAC cells was detected by confocal microscopy whereas beticolin-3 and -12 were not even after a 24 h incubation period. Beticolin-1-induced cell growth inhibition was partially reverted by calcium ionophore suggesting a role of intracellular Ca2+ chelation by beticolin-1 on cell growth inhibition. Furthermore, beticolin-1 blocked up Ras p21 translocation to membrane and induced accumulation of Ras in the cytosol as an inactive form by different ways.
  
  
  CONCLUSIONS
  Beticolins with high hydrophobicity inhibit tumorigenic cell proliferation by different ways.
authors.affiliation: Laboratoire de Biochimie des Interactions Cellulaires, Faculte de Sciences, Universit e de Bourgogne, BP 400, 21011 Dijon Cedex, France. gqding@yahoo.com
authors.forename: G Q
authors.initials: GQ
authors.lastname: Ding
authors.forename: G
authors.initials: G
authors.lastname: Maume
authors.forename: H
authors.initials: H
authors.lastname: Osman
authors.forename: M
authors.initials: M
authors.lastname: Padieu
authors.forename: M L
authors.initials: ML
authors.lastname: Milat
authors.forename: C
authors.initials: C
authors.lastname: Humbert
authors.forename: J P
authors.initials: JP
authors.lastname: Blein
authors.forename: B F
authors.initials: BF
authors.lastname: Maume
mesh_terms: D000302:Adrenal Cortex / Q000166:cytology / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D002118:Calcium / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D005658:Fungi / Q000378:metabolism*; D006576:Heterocyclic Compounds, 4 or More Rings; D057927:Hydrophobic and Hydrophilic Interactions; D009183:Mycotoxins / Q000494:pharmacology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics; D051381:Rats; D014178:Translocation, Genetic
chemical_list: D006576:Heterocyclic Compounds, 4 or More Rings; D009183:Mycotoxins; C113021:beticolin 0; C403640:beticolin 3; C089993:beticolin 1; D016283:Proto-Oncogene Proteins p21(ras); D002118:Calcium